論文

査読有り 国際誌
2022年4月

Establishment of Novel Anti-Mouse CCR3 Monoclonal Antibodies (C3Mab-6 and C3Mab-7) by N-terminal Peptide Immunization.

Monoclonal antibodies in immunodiagnosis and immunotherapy
  • Teizo Asano
  • ,
  • Hiroyuki Suzuki
  • ,
  • Nohara Goto
  • ,
  • Tomohiro Tanaka
  • ,
  • Mika K Kaneko
  • ,
  • Yukinari Kato

41
2
開始ページ
94
終了ページ
100
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1089/mab.2021.0065

The CC chemokine receptor 3 (CCR3) is a member of the G protein-coupled receptor family that is highly expressed in eosinophils and basophils. CCR3 has been proposed as a therapeutic target for human immunodeficiency virus and allergy diagnosis. Therefore, in this study, we developed specific and sensitive monoclonal antibodies (mAbs) for mouse CCR3 (mCCR3), which are useful for flow cytometry by peptide immunization. The established anti-mCCR3 mAbs, C3Mab-6 (rat IgG1, kappa) and C3Mab-7 (rat IgG1, kappa), reacted with mCCR3-overexpressed Chinese hamster ovary-K1 (CHO/mCCR3), in addition to mCCR3-endogenously expressed cell lines, such as P388 (mouse lymphoid neoplasma) and J774-1 (mouse macrophage-like) through flow cytometry. Kinetic analyses using flow cytometry indicated that the dissociation constants (KDs) of C3Mab-6 for CHO/mCCR3, P388, and J774-1 cells were 8.7 × 10-9 M, 1.4 × 10-7 M, and 1.7 × 10-7 M, respectively, whereas the KDs of C3Mab-7 for these cell lines were 3.7 × 10-9 M, 5.1 × 10-7 M, and 3.1 × 10-7 M, respectively. Results also indicated that C3Mab-6 and C3Mab-7 are useful for detecting cells expressing CCR3 through flow cytometry, thereby making them potentially beneficial for treating CCR3-expressing cells.

リンク情報
DOI
https://doi.org/10.1089/mab.2021.0065
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35471054
ID情報
  • DOI : 10.1089/mab.2021.0065
  • PubMed ID : 35471054

エクスポート
BibTeX RIS